Literature DB >> 10148323

Laboratory evaluation of a low prime closed-circuit cardiopulmonary bypass system.

J J Sistino1, R E Michler, L B Mongero.   

Abstract

We have explored the potential advantages of a low prime closed-circuit cardiopulmonary bypass (CPB) system using a non-human primate model. Although manufacturers have reduced priming volumes in individual CPB components, the standard circuit volume remains high because of the tubing diameter and length necessary for gravity drainage. By replacing gravity drainage with the negative pressure generated by a centrifugal pump, we can realize significant tubing volume reduction. Closed-circuit bypass was conducted on 13 baboons ranging from 5-15 kg. The circuit consisted of a centrifugal pump, a hollow fiber oxygenator, and 1/4" arterial and venous tubing. The design of the circuit included the capacity to remove a limited amount of venous air. Circulatory arrest during deep hypothermia with volume displacement into a reservoir was also accomplished with this circuit. The potential benefits of this low prime closed-circuit bypass system include blood conservation and reduction in blood surface area contact. The future safe clinical use of this type of closed-circuit bypass for routine open heart surgery will depend upon the incorporation of a device in the venous line to remove air. This is the greatest threat to patient safety in a closed circuit system and its use for open chest surgery must wait until an efficient venous air elimination device is available.

Entities:  

Mesh:

Year:  1993        PMID: 10148323

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  1 in total

1.  Pediatric cardiopulmonary bypass adaptations for long-term survival of baboons undergoing pulmonary artery replacement.

Authors:  Carrie Whittaker; Gary Grist; Arthur Bert; Kathleen Brasky; Stacy Neighbors; Christopher McFall; Stephen L Hilbert; William B Drake; Michael Cromwell; Barbara Mueller; Gary K Lofland; Richard A Hopkins
Journal:  J Extra Corpor Technol       Date:  2010-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.